$14.09
-0.25-1.74%
At close: -
$14.80
0.715.04%
After Hours: Nov 22, 8:59 AM EDT
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.40 | $-0.43 | 6.98 % |
Jun 2024 | 2024-08-13 | $-0.39 | $-0.35 | -11.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Contineum Therapeutics (CTNM) is scheduled to report earnings on February 16, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-0.40, which beat the estimate of $-0.43.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.